2011
DOI: 10.1007/s12275-011-1153-7
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and identification of lipopeptide antibiotics from Paenibacillus elgii B69 with inhibitory activity against methicillin-resistant Staphylococcus aureus

Abstract: Two lipopeptide antibiotics, pelgipeptins C and D, were isolated from Paenibacillus elgii B69 strain. The molecular masses of the two compounds were both determined to be 1,086 Da. Mass-spectrometry, amino acid analysis and NMR spectroscopy indicated that pelgipeptin C was the same compound as BMY-28160, while pelgipeptin D was identified as a new antibiotic of the polypeptin family. These two peptides were active against all the tested microorganisms, including antibiotic-resistant pathogenic bacterial strain… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
28
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 42 publications
(29 citation statements)
references
References 26 publications
0
28
1
Order By: Relevance
“…Polypeptins, octapeptins, pelgipeptins, gavaserin and saltavalin are LPs isolated from Paenibacillus sp. strains, reported before by other scientists, and should also be included in this collection [136, 152155]. …”
Section: Resultsmentioning
confidence: 99%
“…Polypeptins, octapeptins, pelgipeptins, gavaserin and saltavalin are LPs isolated from Paenibacillus sp. strains, reported before by other scientists, and should also be included in this collection [136, 152155]. …”
Section: Resultsmentioning
confidence: 99%
“…[144]. Similarly, a new cyclic lipopeptide antibiotic from Pa. tianmuensis Battacin (Octapeptin B5) was reported active against multidrug-resistant Gram-negative bacteria [145].…”
Section: Lipopeptide Surfactants As Antibacterial Agentsmentioning
confidence: 98%
“…The most frequent products are lipopeptides [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16], peptide/polyketide hybrids [17,18], as well as lantibiotics [19,20]. Such products qualify Paenibacillus strains for applications in agriculture, medicine, and biotechnology.…”
Section: Introductionmentioning
confidence: 99%